Boothbay Fund Management’s Revolution Medicines Warrant RVMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-8,144
Closed -$356K – 1730
2024
Q4
$356K Hold
8,144
– – 0.01% 1016
2024
Q3
$369K Hold
8,144
– – 0.01% 1121
2024
Q2
$316K Hold
8,144
– – 0.01% 1143
2024
Q1
$262K Hold
8,144
– – 0.01% 1243
2023
Q4
$234K Buy
+8,144
New +$3.64K 0.01% 1279

Other funds holding RVMDW

Boothbay Fund Management's RVMDW Position: Q1 2025 in Review

Boothbay Fund Management sold out of Revolution Medicines Warrant (RVMDW) in Q1 2025, closing a stake of 8,144 shares — an estimated $356K sold.

Boothbay Fund Management first reported a position in RVMDW in Q4 2023 and held it in 5 quarters. The position peaked at $369K in Q3 2024. 24 funds tracked by Wall St. Rank hold RVMDW as of Q1 2025.

  • Boothbay Fund Management reported no remaining Revolution Medicines Warrant position as of Q1 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 8,144 Revolution Medicines Warrant shares in Q1 2025, an estimated $356K.
  • Boothbay Fund Management first reported a position in Revolution Medicines Warrant in Q4 2023 and held it in 5 quarters.
  • Boothbay Fund Management's Revolution Medicines Warrant position peaked at $369K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held Revolution Medicines Warrant as of Q1 2025.

Based on Boothbay Fund Management's 13F filing for Q1 2025, filed 15 May 2025.